Physician profile
Amber Thomas
NPI 1861790404
$1,483.99
in general payments reported to CMS, 2019-2025
18 companies · $64.28 in 2025
The $64.28 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $131 · 2023: $345 · 2024: $827 · 2025: $64.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $738.33 | 2023-2024 | Varithena Administration Pack, Athletis |
| Bard Peripheral Vascular, INC. | $281.49 | 2023-2025 | Venovo, Pristine, Atlas |
| Janssen Pharmaceuticals, INC | $78.21 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $40.00 | 2022 | |
| Abbvie INC. | $38.77 | 2021 | |
| Medtronic, INC. | $38.23 | 2023 | Linq II, Venaseal |
| Biotronik INC. | $34.54 | 2022 | |
| W. L. Gore & Associates, INC. | $26.73 | 2023 | Gore Cardioform Septal Occluder |
| Myovant Sciences INC. | $25.17 | 2022 | |
| Axonics, INC. | $24.63 | 2023 | Axonics |
| Astrazeneca Pharmaceuticals LP | $23.36 | 2021-2022 | |
| Philips North America LLC | $21.49 | 2023 | |
| Cashflow Solutions, LLC | $21.48 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Abc Home Medical Supply, INC. | $19.49 | 2022 | |
| Abbott Laboratories | $19.15 | 2024 | Amplatzer Amulet |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.72 | 2025 | Austedo Xr |
| Arbor Pharmaceuticals, INC. | $17.89 | 2021 | |
| Curonix LLC | $16.31 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.